β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study

201889 citationsJournal Articlebronze Open Access

Authors

Emmanuel Sorbets · Université Sorbonne Paris Nord

Philippe Gabríel Steg · French Clinical Research Infrastructure Network

Robin Young · University of Glasgow

Nicolas Danchin · Délégation Paris 5

Nicola Greenlaw · University of Glasgow

Ian Ford · University of Glasgow

Michał Tendera ·

Abstract

In this contemporary cohort of stable CAD, β-blocker use was associated with lower 5-year mortality only in patients enrolled in the year following MI. Use of calcium antagonists was not associated with superior mortality, regardless of history of MI.

Topics & Keywords

Blood Pressure and Hypertension Studies Cardiac Imaging and Diagnostics Cardiac, Anesthesia and Surgical Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 40, Issue 18, pp. 1399-1407

DOI: 10.1093/eurheartj/ehy811

Field-Weighted Citation Impact: 7.17